New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A4944

Introduced
12/8/22  

Caption

Authorizes medical cannabis for treatment of sickle cell anemia.

Companion Bills

NJ S3394

Same As Authorizes medical cannabis for treatment of sickle cell anemia.

Previously Filed As

NJ A913

Authorizes medical cannabis for treatment of sickle cell anemia.

NJ S3394

Authorizes medical cannabis for treatment of sickle cell anemia.

NJ S2392

Authorizes medical cannabis for treatment of sickle cell anemia.

NJ S342

Authorizes home cultivation of medical cannabis.

NJ A997

Authorizes home cultivation of medical cannabis.

NJ A846

Authorizes home cultivation of medical cannabis.

NJ S1393

Authorizes home cultivation of medical cannabis.

NJ A4938

Provides health care practitioners discretion to determine which medical conditions could qualify patients for use of medical cannabis.

NJ S3484

Provides health care practitioners discretion to determine which medical conditions could qualify patients for use of medical cannabis.

NJ A4649

Authorizes cannabis cultivation on land receiving farmland assessment.

Similar Bills

NJ S3394

Authorizes medical cannabis for treatment of sickle cell anemia.

NJ S2392

Authorizes medical cannabis for treatment of sickle cell anemia.

NJ A913

Authorizes medical cannabis for treatment of sickle cell anemia.

NJ A4938

Provides health care practitioners discretion to determine which medical conditions could qualify patients for use of medical cannabis.

NJ S3484

Provides health care practitioners discretion to determine which medical conditions could qualify patients for use of medical cannabis.

NJ S342

Authorizes home cultivation of medical cannabis.

NJ A997

Authorizes home cultivation of medical cannabis.

NJ A846

Authorizes home cultivation of medical cannabis.